Women's Health Study

The Women's Health Study (WHS) was a randomized, double-blind, placebo-controlled trial evaluating the balance of benefits and risks of low-dose aspirin and vitamin E in reducing risks of cardiovascular disease and cancer among 39,876 U.S. female health professionals aged 45 and older. Other areas of interest include the role of aspirin in the prevention of migraine and the role of vitamin E and aspirin in the prevention of vision problems, including cataract and age-related macular degeneration, and cognitive decline.

For a summary of the main findings on aspirin and cardiovascular disease, click here; for a summary of the main findings on aspirin and cancer, click here; and for a summary of the main findings on vitamin E and cardiovascular disease and cancer, click here.